Fluidigm Corp (FLDM) - Medical Equipment - Deals and Alliances Profile

Fluidigm Corp (FLDM) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME53599D
  • |
  • Pages: 53
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instruments, integrated fluidic circuits and assays and reagents to clinical research laboratories; academic institutions; biopharmaceutical, biotechnology, and agricultural biotechnology companies; and contract research organizations worldwide. Fluidigm manufactures its products through multi-layer soft lithography technology and CyTOF technology, among others. The company distributes its systems through direct sales force and support organizations across North America, Europe and Asia-Pacific; and also through a network of distributors across Europe, Latin America, the Middle East and Asia-Pacific. Fluidigm is headquartered in South San Francisco, California, the US.

Fluidigm Corp (FLDM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Fluidigm Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Fluidigm Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Fluidigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Fluidigm Corp, Medical Equipment, Deal Details 11

Venture Financing 11

Fluidigm Raises USD76.80 Million in Venture Financing 11

Partnerships 12

Fluidigm Enters into Licensing Agreement with Baylor Genetics Labs 12

Fluidigm Enters into Co-Marketing Agreement with Visiopharm 13

Fluidigm and Ascendas Genomics Enter into Partnership 14

Fluidigm Enters into Distribution Agreement with GenomOncology 15

OpGen Enters into Co-Development Agreement with Fluidigm 16

Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 17

Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 19

Equity Offering 20

Fluidigm Raises USD30 Million in Public Offering of Shares 20

Fluidigm Completes Public Offering Of Common Stock For USD 60 Million 21

Debt Offering 23

Fluidigm Completes Public Offering Of Notes Due 2034 For USD 201.3 Million 23

Acquisition 25

Fluidigm Completes Acquisition Of DVS Sciences For USD 207.5 Million 25

Fluidigm Corp-Key Competitors 27

Fluidigm Corp-Key Employees 28

Fluidigm Corp-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Financial Announcements 30

Aug 02, 2018: Fluidigm announces second quarter 2018 financial results 30

May 03, 2018: Fluidigm Announces First Quarter Financial Results and Operational Progress 32

Feb 08, 2018: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress 34

Nov 02, 2017: Fluidigm Announces Third Quarter Financial Results and Operational Progress 36

Aug 03, 2017: Fluidigm Announces Second Quarter Financial Results and Operational Progress 38

May 04, 2017: Fluidigm Announces First Quarter Financial Results 40

Feb 08, 2017: Fluidigm Announces Q4 And Full Year 2016 Financial Results 43

Jan 09, 2017: Fluidigm Announces Preliminary Revenue For The Fourth Quarter And Full Year 45

Corporate Communications 46

Jun 26, 2018: Fluidigm Appoints David King As Vice President, Research and Development, Genomics 46

Apr 23, 2018: Fluidigm Appoints Brad Kreger As Senior Vice President, Global Operations 47

Mar 27, 2017: Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors 48

Product News 49

Aug 09, 2018: Fluidigm to host 2nd annual imaging mass cytometry user group meeting 49

Apr 13, 2018: Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research 50

Oct 24, 2017: Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues 51

Oct 18, 2017: Fluidigm to Unveil High-Parameter Tissue Imaging System 52

Appendix 53

Methodology 53

About GlobalData 53

Contact Us 53

Disclaimer 53

List of Figures

Fluidigm Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Fluidigm Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Fluidigm Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Fluidigm Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

Fluidigm Corp, Medical Equipment, Key Facts, 2017 2

Fluidigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Fluidigm Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Fluidigm Corp, Deals By Market, 2012 to YTD 2018 9

Fluidigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Fluidigm Raises USD76.80 Million in Venture Financing 11

Fluidigm Enters into Licensing Agreement with Baylor Genetics Labs 12

Fluidigm Enters into Co-Marketing Agreement with Visiopharm 13

Fluidigm and Ascendas Genomics Enter into Partnership 14

Fluidigm Enters into Distribution Agreement with GenomOncology 15

OpGen Enters into Co-Development Agreement with Fluidigm 16

Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 17

Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 19

Fluidigm Raises USD30 Million in Public Offering of Shares 20

Fluidigm Completes Public Offering Of Common Stock For USD 60 Million 21

Fluidigm Completes Public Offering Of Notes Due 2034 For USD 201.3 Million 23

Fluidigm Completes Acquisition Of DVS Sciences For USD 207.5 Million 25

Fluidigm Corp, Key Competitors 27

Fluidigm Corp, Key Employees 28

Fluidigm Corp, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Fluidigm Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17840
Site License
USD 500 INR 35680
Corporate User License
USD 750 INR 53520

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com